Tuesday 26 October 2010
Lithuanian Kirin Amgen ECJ reference: a local lawyer comments
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
Readers will recall the recent ruling of the Court of Justice of the European Union in Case C‑66/09, Kirin Amgen Inc. v Lietuvos Respublikos valstybinis patentų biuras, Amgen Europe BV, noted on The SPC Blog here. A note on this decision, "ECJ preliminary ruling on patent law referral from Supreme Court", has now been published on International Law Office. This note, written by Edita Ivanauskienė (Lideika Petrauskas Valiunas ir partneriai LAWIN), concludes with the observation that the Court of Justice took a strict position regarding the issuing of supplementary protection certificates in a new Member State, demonstrating "the potential consequences of EU accession for the medicinal product's patent protection".
... rising from the ashes of the expired patent
2,097 readers now receive The SPC Blog by email circular. Why don't you join them?
To subscribe, just type your email address in the box below, then click the 'Subscribe' button
The SPC ...
... rising from the ashes of the expired patent
Pageviews since June 2008
Contributors to The SPC Blog
Key cases and materials on SPCs
The SPC Blog has set up an auxiliary SPC Blog: Resources website, which offers links to relevant national and European SPC case law as well as to basic legal texts.
If you know of anything that should be on the Resources site but isn't, please email The SPC Blog here and let us know.
Useful links to organisations
BioIndustry Association (BIA)
European Federation of Pharmaceutical Industries and Associations (EFPIA)
European Generic Medicines Association (EGA)
European Medicines Agency (EMEA)
International Generic Pharmaceutical Alliance (IGPA)
Medicines for Children Research Network (MCFN)
United Kingdom Intellectual Property Office (UK-IPO) Guide for SPC applicants here
European Federation of Pharmaceutical Industries and Associations (EFPIA)
European Generic Medicines Association (EGA)
European Medicines Agency (EMEA)
International Generic Pharmaceutical Alliance (IGPA)
Medicines for Children Research Network (MCFN)
United Kingdom Intellectual Property Office (UK-IPO) Guide for SPC applicants here
Would you like to receive each post by email?
2,097 readers now receive The SPC Blog by email circular. Why don't you join them?
To subscribe, just type your email address in the box below, then click the 'Subscribe' button
More useful links here
Most frequently-read SPC Blog postings
-
Celebrating its 20th anniversary, the BioIndustry Association has designed an attractive and colourful logo for its 2009 Forum. This event t...
-
The SPC Blog has recently received an email from Michael Lin (Marks&Clerk, Hong Kong), who helpfully tells us: "I’ve received quit...
-
A friend of the SPC Blog has posed the following question for our readers, based upon the fact that Monaco does not appear to have made any...
-
Last week's Opinion of the Advocate General in Case C-125/10 Merck (noted briefly here on The SPC Blog) is still not available in Englis...
-
Bianca-Lucia Vos and Klemens Stratmann of Hoffmann-Eitle have generously provided a copy of a recent decision of the Higher Regional Court o...
RSS feed
Blog Archive
-
▼
2010
(78)
-
▼
October
(10)
- Lithuanian Kirin Amgen ECJ reference: a local lawy...
- Yeda application heads for ECJ on indirect/contrib...
- Medeva note in latest BioSLR
- When will the "suitable opportunity" arise for cha...
- Paediatric Extensions in European Countries
- Patent extensions: some academic perspectives?
- Date for the 2011 SPC Blog's seminar: when is best...
- Positive opinions on PIPs
- New UK Office Manual changes affect SPCs
- Even more about HPV vaccines and SPCs
-
▼
October
(10)
PageRank
Legal notices
© The contributors 2008-2020. If you'd like to reproduce, distribute or transmit any of the text written by the members of The SPC Blog's team, please feel free to do so, crediting this weblog as your source. None of the material posted on this weblog should be relied upon as legal advice in any specific instance. If you need legal advice please consult an appropriately qualified professional adviser.
Privacy policy
If you subscribe to the blog, The SPC Blog collects your email address which may include personal data such as the whole or part of your name. The SPC Blog relies on its legitimate interests to process this data so that we can keep you up to date with developments as reported on the SPC Blog. The SPC Blog does not make any other use of this data. It takes care to maintain its confidentiality and does not share your data with third parties. You have the right to unsubscribe from receiving emails from the SPC Blog at any time by emailing : the-spc-blog+unsubscribe@googlegroups.com.
Some blog posts or comments may include personal data such as the name of the person who wrote or contributed to a blogpost, spoke at an event, made a comment or similar. Again, the SPC Blog relies on its legitimate interests to process this data. If you would like to have your personal data removed, please email spcblogqueries@gmail.com.
The SPC Blog uses a variety of tools which are provided by Google and Blogger / Blogspot to share its information. For example, the Blog is hosted on the Blogger platform and the SPC Blog uses Google Groups to manage and share the emails. The SPC Blog has no control over these tools and does not collect any data as a result of their use. Google may collect/or process your data in these circumstances. If you have any concerns regarding Google’s use of your personal data following use of these tools, please read Google’s policy. The blog also uses a number of other tools /cookies to improve the experience on the blog and you can find out more information about them here: Add This, Pr Checker, Feed Burner.
No comments:
Post a Comment